Tickerover
Healthcare

CI Stock Analysis

The Cigna Group · current price $278.88 (+0.46% today)

Mixed signals — neither side has the edge here. The thesis lacks a clear edge from current data.
★★★
Average
📊

The six-pillar scorecard

Momentum
45
Losing steam
price trend
Growth
25
Barely growing
sales & profit growth
Quality
49
Some weak spots
profitability & balance sheet
Valuation
90
Looks cheap
is the price fair?
Sentiment
46
Mixed views
analyst & crowd mood
Risk
84
Low risk
volatility & drawdown

Each pillar is scored 0-100 inside the stock’s own peer group, so a chipmaker is measured against chipmakers. These are quality descriptors, not buy or sell signals.

📉

The picture

What drove the scoreThe seven components contributing most, each read out of 100.
GrowthGrowth: 6060RSI zoneRSI zone: 7070Relative strengthRelative strength: 6565Analyst consensusAnalyst consensus: 7070Earnings qualityEarnings quality: 7878News sentimentNews sentiment: 9595Near 52w highNear 52w high: 7575
Margin profileWhat survives each step down the income statement.
GrossGross: 9.1%9.1%OperatingOperating: 4.0%4.0%NetNet: 2.3%2.3%Free cash flowFree cash flow: 3.2%3.2%
EPS surpriseReported EPS against estimate, last four quarters.
2026-06: +2.4% vs estimate+2%2026-062026-03: +2.4% vs estimate+2%2026-032025-12: +2.5% vs estimate+2%2025-122025-09: +2.5% vs estimate+2%2025-09
👁

Hype Check

Reading CI’s price and volume history…

The audit — what has to hold for this thesis

Checking the areas that decide this thesis…

AI-generated from the company’s own filings and recent coverage, and it can be incomplete or wrong. A PASS is a reading of the cited evidence, not a verified fact and not a reason to buy. Follow each citation to the source.

🛡

Dilution Check

Reading CI’s filings…

📣

Latest earnings

LAST EARNINGS The Cigna Group (CI)

Latest earnings

EPS
$7.83 vs $7.64 est · +2.5% vs estimate BEAT
Revenue
$71.40B · +2.7% YoY
Stock reaction (1M)
-3.0%
Beat streak
4 of last 4 quarters
💰

Valuation

P/E
11.5×
Forward P/E
8.3×
PEG
0.83
Price / Sales
0.3×
Price / Book
1.7×
EV / EBITDA
7.7×
Analyst target
$341.42
Target range
$290.00 – $400.00
Implied upside
+22.4%
🩺

Financial health

Gross margin
9.1%
Operating margin
4.0%
Net margin
2.3%
FCF margin
3.2%
Return on equity
16.8%
Debt / equity
0.74
Revenue growth YoY
+6.7%
EPS growth YoY
+10.2%
📈

Technicals

$239.5152-week range$315.47
RSI (14)
48
50-day MA
$283.35
200-day MA
$279.28
ATR (14)
5.65
Beta
0.32
1-month return
-3.0%
🗓️

Earnings

QuarterEPSEst.SurpriseResult
2025-09-30$7.83$7.64+2.5%Beat
2025-12-31$8.08$7.88+2.5%Beat
2026-03-31$7.79$7.61+2.4%Beat
2026-06-30$7.78$7.60+2.4%Beat
Beat 4 of the last 4 quarters.
🏛️

Ownership & risk

Short % of float
0.02%
Dividend yield
2.24%
Beta
0.32
📰

Latest news on CI

🔗

Similar stocks in Healthcare

Frequently asked

What is CI's Quant Score?

The Cigna Group (CI) currently has a TickerMover Quant Score of 59/100, rated ★★★ Average. The Quant Score is a quantitative composite across six research pillars — momentum, quality, growth, valuation, sentiment and risk. It is research information, not investment advice.

Is The Cigna Group (CI) a buy?

TickerMover does not give buy or sell recommendations. CI scores 59/100 (★★★ Average) on our quantitative research model — a screening signal, not a personal recommendation. Do your own research, and consider an FCA-authorised adviser before investing.

How often is CI's score updated?

CI's Quant Score and underlying data refresh through US market hours (about every five minutes), using public market and fundamental data.

Get the full live dashboard

Real-time scoring, conflict detection, Reverse DCF and peer comparison — free while in beta.

Open the dashboard for CI →